17 alpha-hydroxyprogesterone caproate has been researched along with nomifensine in 1 studies
Studies (17 alpha-hydroxyprogesterone caproate) | Trials (17 alpha-hydroxyprogesterone caproate) | Recent Studies (post-2010) (17 alpha-hydroxyprogesterone caproate) | Studies (nomifensine) | Trials (nomifensine) | Recent Studies (post-2010) (nomifensine) |
---|---|---|---|---|---|
517 | 88 | 251 | 1,127 | 111 | 65 |
Protein | Taxonomy | 17 alpha-hydroxyprogesterone caproate (IC50) | nomifensine (IC50) |
---|---|---|---|
D | Rattus norvegicus (Norway rat) | 2.724 | |
D(3) dopamine receptor | Rattus norvegicus (Norway rat) | 2.724 | |
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.631 | |
Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | 0.1642 | |
D(1B) dopamine receptor | Rattus norvegicus (Norway rat) | 2.724 | |
D(4) dopamine receptor | Rattus norvegicus (Norway rat) | 2.724 | |
Sodium-dependent serotonin transporter | Homo sapiens (human) | 8.7096 | |
Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | 3.115 | |
Cytochrome P450 2C19 | Homo sapiens (human) | 0.0316 | |
D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 2.724 | |
Sodium-dependent dopamine transporter | Homo sapiens (human) | 0.0781 | |
Transporter | Rattus norvegicus (Norway rat) | 2.7033 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for 17 alpha-hydroxyprogesterone caproate and nomifensine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |